 | • レポートコード：QYR9N7496 • 出版社/出版日：QYResearch / 2019年6月14日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、95ページ • 納品方法：Eメール（受注後２～3営業日） • 産業分類：医療・製薬・バイオ |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当資料は、大鬱病性障害のグローバル市場について調査・分析したレポートで、種類別（薬物療法、生物学的療法、瞑想、理学療法、その他）、用途別（25歳未満、25〜45歳、45歳以上）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。 ・大鬱病性障害の世界市場規模 ・主要企業別市場シェア ・大鬱病性障害の世界市場規模：種類別（薬物療法、生物学的療法、瞑想、理学療法、その他） ・大鬱病性障害の世界市場規模：用途別（25歳未満、25〜45歳、45歳以上） ・大鬱病性障害のアメリカ市場規模（種類別、用途別） ・大鬱病性障害のヨーロッパ市場規模（種類別、用途別） ・大鬱病性障害の中国市場規模（種類別、用途別） ・大鬱病性障害の日本市場規模（種類別、用途別） ・大鬱病性障害の東南アジア市場規模（種類別、用途別） ・大鬱病性障害のインド市場規模（種類別、用途別） ・大鬱病性障害の中南米市場規模（種類別、用途別） ・主要企業別分析（企業概要、製品動向、販売量など） ・大鬱病性障害の世界市場予測（2019年-2025年） ・大鬱病性障害の地域別市場予測（2019年-2025年） ... |
Major depressive disorder, also known as major depression and clinical depression, is a mental disorder characterized by loss of interest and pleasure in enjoyable environment. People are affected in different ways by major depression. Some people have trouble sleeping, feel agitated and irritable, and have sudden weight loss. Moreover, they can have other mental and physical symptoms such as fatigue, memory loss, feeling of hopelessness, body aches, headaches, and thoughts of suicide.In terms of geography, North America dominates the global major depressive disorder market due to increased awareness about various depression conditions in the region. The U.S. represents the largest market for major depressive disorder in North America, followed by Canada. In Europe, Germany, France, the U.K., Italy, and Spain account for a major share of the major depressive disorder market. This market in Asia is expected to expand at a significant rate over the next five years. This is due to various companies setting up manufacturing facilities in the region. Moreover, increasing awareness about various depression episodes and rise in geriatric population are also driving the growth of the market in the region. India, China, and Japan are expected to be the fastest growing major depressive disorder markets in Asia.
In 2018, the global Major Depressive Disorder market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Major Depressive Disorder status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Major Depressive Disorder development in United States, Europe and China.
The key players covered in this study
Pfizer
Eli Lilly
H. Lundbeck
Otsuka Pharmaceutical
AstraZeneca
Alkermes
Takeda Pharmaceutical
Naurex
Euthymics Bioscience
E-therapeutics
Market segment by Type, the product can be split into
Drugs Therapy
Biological Therapy
Meditation
Physiotherapy
Other
Market segment by Application, split into
Under 25 Years Old
25-45 Years Old
Above 45 Years Old
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Major Depressive Disorder status, future forecast, growth opportunity, key market and key players.
To present the Major Depressive Disorder development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Major Depressive Disorder are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Major Depressive Disorder Market Size Growth Rate by Type (2014-2025)
1.4.2 Drugs Therapy
1.4.3 Biological Therapy
1.4.4 Meditation
1.4.5 Physiotherapy
1.4.6 Other
1.5 Market by Application
1.5.1 Global Major Depressive Disorder Market Share by Application (2014-2025)
1.5.2 Under 25 Years Old
1.5.3 25-45 Years Old
1.5.4 Above 45 Years Old
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Major Depressive Disorder Market Size
2.2 Major Depressive Disorder Growth Trends by Regions
2.2.1 Major Depressive Disorder Market Size by Regions (2014-2025)
2.2.2 Major Depressive Disorder Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Major Depressive Disorder Market Size by Manufacturers
3.1.1 Global Major Depressive Disorder Revenue by Manufacturers (2014-2019)
3.1.2 Global Major Depressive Disorder Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Major Depressive Disorder Market Concentration Ratio (CR5 and HHI)
3.2 Major Depressive Disorder Key Players Head office and Area Served
3.3 Key Players Major Depressive Disorder Product/Solution/Service
3.4 Date of Enter into Major Depressive Disorder Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Major Depressive Disorder Market Size by Type (2014-2019)
4.2 Global Major Depressive Disorder Market Size by Application (2014-2019)
5 United States
5.1 United States Major Depressive Disorder Market Size (2014-2019)
5.2 Major Depressive Disorder Key Players in United States
5.3 United States Major Depressive Disorder Market Size by Type
5.4 United States Major Depressive Disorder Market Size by Application
6 Europe
6.1 Europe Major Depressive Disorder Market Size (2014-2019)
6.2 Major Depressive Disorder Key Players in Europe
6.3 Europe Major Depressive Disorder Market Size by Type
6.4 Europe Major Depressive Disorder Market Size by Application
7 China
7.1 China Major Depressive Disorder Market Size (2014-2019)
7.2 Major Depressive Disorder Key Players in China
7.3 China Major Depressive Disorder Market Size by Type
7.4 China Major Depressive Disorder Market Size by Application
8 Japan
8.1 Japan Major Depressive Disorder Market Size (2014-2019)
8.2 Major Depressive Disorder Key Players in Japan
8.3 Japan Major Depressive Disorder Market Size by Type
8.4 Japan Major Depressive Disorder Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Major Depressive Disorder Market Size (2014-2019)
9.2 Major Depressive Disorder Key Players in Southeast Asia
9.3 Southeast Asia Major Depressive Disorder Market Size by Type
9.4 Southeast Asia Major Depressive Disorder Market Size by Application
10 India
10.1 India Major Depressive Disorder Market Size (2014-2019)
10.2 Major Depressive Disorder Key Players in India
10.3 India Major Depressive Disorder Market Size by Type
10.4 India Major Depressive Disorder Market Size by Application
11 Central & South America
11.1 Central & South America Major Depressive Disorder Market Size (2014-2019)
11.2 Major Depressive Disorder Key Players in Central & South America
11.3 Central & South America Major Depressive Disorder Market Size by Type
11.4 Central & South America Major Depressive Disorder Market Size by Application
12 International Players Profiles
12.1 Pfizer
12.1.1 Pfizer Company Details
12.1.2 Company Description and Business Overview
12.1.3 Major Depressive Disorder Introduction
12.1.4 Pfizer Revenue in Major Depressive Disorder Business (2014-2019)
12.1.5 Pfizer Recent Development
12.2 Eli Lilly
12.2.1 Eli Lilly Company Details
12.2.2 Company Description and Business Overview
12.2.3 Major Depressive Disorder Introduction
12.2.4 Eli Lilly Revenue in Major Depressive Disorder Business (2014-2019)
12.2.5 Eli Lilly Recent Development
12.3 H. Lundbeck
12.3.1 H. Lundbeck Company Details
12.3.2 Company Description and Business Overview
12.3.3 Major Depressive Disorder Introduction
12.3.4 H. Lundbeck Revenue in Major Depressive Disorder Business (2014-2019)
12.3.5 H. Lundbeck Recent Development
12.4 Otsuka Pharmaceutical
12.4.1 Otsuka Pharmaceutical Company Details
12.4.2 Company Description and Business Overview
12.4.3 Major Depressive Disorder Introduction
12.4.4 Otsuka Pharmaceutical Revenue in Major Depressive Disorder Business (2014-2019)
12.4.5 Otsuka Pharmaceutical Recent Development
12.5 AstraZeneca
12.5.1 AstraZeneca Company Details
12.5.2 Company Description and Business Overview
12.5.3 Major Depressive Disorder Introduction
12.5.4 AstraZeneca Revenue in Major Depressive Disorder Business (2014-2019)
12.5.5 AstraZeneca Recent Development
12.6 Alkermes
12.6.1 Alkermes Company Details
12.6.2 Company Description and Business Overview
12.6.3 Major Depressive Disorder Introduction
12.6.4 Alkermes Revenue in Major Depressive Disorder Business (2014-2019)
12.6.5 Alkermes Recent Development
12.7 Takeda Pharmaceutical
12.7.1 Takeda Pharmaceutical Company Details
12.7.2 Company Description and Business Overview
12.7.3 Major Depressive Disorder Introduction
12.7.4 Takeda Pharmaceutical Revenue in Major Depressive Disorder Business (2014-2019)
12.7.5 Takeda Pharmaceutical Recent Development
12.8 Naurex
12.8.1 Naurex Company Details
12.8.2 Company Description and Business Overview
12.8.3 Major Depressive Disorder Introduction
12.8.4 Naurex Revenue in Major Depressive Disorder Business (2014-2019)
12.8.5 Naurex Recent Development
12.9 Euthymics Bioscience
12.9.1 Euthymics Bioscience Company Details
12.9.2 Company Description and Business Overview
12.9.3 Major Depressive Disorder Introduction
12.9.4 Euthymics Bioscience Revenue in Major Depressive Disorder Business (2014-2019)
12.9.5 Euthymics Bioscience Recent Development
12.10 E-therapeutics
12.10.1 E-therapeutics Company Details
12.10.2 Company Description and Business Overview
12.10.3 Major Depressive Disorder Introduction
12.10.4 E-therapeutics Revenue in Major Depressive Disorder Business (2014-2019)
12.10.5 E-therapeutics Recent Development
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Major Depressive Disorder Key Market Segments
Table Key Players Major Depressive Disorder Covered
Table Global Major Depressive Disorder Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Major Depressive Disorder Market Size Market Share by Type 2014-2025
Figure Drugs Therapy Figures
Table Key Players of Drugs Therapy
Figure Biological Therapy Figures
Table Key Players of Biological Therapy
Figure Meditation Figures
Table Key Players of Meditation
Figure Physiotherapy Figures
Table Key Players of Physiotherapy
Figure Other Figures
Table Key Players of Other
Table Global Major Depressive Disorder Market Size Growth by Application 2014-2025 (Million US$)
Figure Under 25 Years Old Case Studies
Figure 25-45 Years Old Case Studies
Figure Above 45 Years Old Case Studies
Figure Major Depressive Disorder Report Years Considered
Table Global Major Depressive Disorder Market Size 2014-2025 (Million US$)
Figure Global Major Depressive Disorder Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Major Depressive Disorder Market Size by Regions 2014-2025 (Million US$)
Table Global Major Depressive Disorder Market Size by Regions 2014-2019 (Million US$)
Table Global Major Depressive Disorder Market Share by Regions 2014-2019
Figure Global Major Depressive Disorder Market Share by Regions 2014-2019
Figure Global Major Depressive Disorder Market Share by Regions 2019
Table Market Top Trends
Table Global Major Depressive Disorder Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Major Depressive Disorder Market Share by Manufacturers (2014-2019)
Figure Global Major Depressive Disorder Market Share by Manufacturers in 2018
Table Global Major Depressive Disorder Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Major Depressive Disorder Product/Solution/Service
Table Date of Enter into Major Depressive Disorder Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Major Depressive Disorder Market Size by Type (2014-2019) (Million US$)
Table Global Major Depressive Disorder Market Size Share by Type (2014-2019)
Figure Global Major Depressive Disorder Market Size Market Share by Type (2014-2019)
Table Global Major Depressive Disorder Market Size by Application (2014-2019) (Million US$)
Table Global Major Depressive Disorder Market Size Share by Application (2014-2019)
Figure Global Major Depressive Disorder Market Size Market Share by Application (2014-2019)
Figure Global Major Depressive Disorder Revenue Market Share by Application in 2018
Figure United States Major Depressive Disorder Market Size 2014-2019 (Million US$)
Table United States Key Players Major Depressive Disorder Revenue (2018-2019) (Million US$)
Table United States Key Players Major Depressive Disorder Market Share (2018-2019)
Table United States Major Depressive Disorder Market Size by Type (2014-2019) (Million US$)
Table United States Major Depressive Disorder Market Share by Type (2014-2019)
Table United States Major Depressive Disorder Market Size by Application (2014-2019) (Million US$)
Table United States Major Depressive Disorder Market Share by Application (2014-2019)
Figure Europe Major Depressive Disorder Market Size 2014-2019 (Million US$)
Table Europe Key Players Major Depressive Disorder Revenue (2018-2019) (Million US$)
Table Europe Key Players Major Depressive Disorder Market Share (2018-2019)
Table Europe Major Depressive Disorder Market Size by Type (2014-2019) (Million US$)
Table Europe Major Depressive Disorder Market Share by Type (2014-2019)
Table Europe Major Depressive Disorder Market Size by Application (2014-2019) (Million US$)
Table Europe Major Depressive Disorder Market Share by Application (2014-2019)
Figure China Major Depressive Disorder Market Size 2014-2019 (Million US$)
Table China Key Players Major Depressive Disorder Revenue (2018-2019) (Million US$)
Table China Key Players Major Depressive Disorder Market Share (2018-2019)
Table China Major Depressive Disorder Market Size by Type (2014-20189) (Million US$)
Table China Major Depressive Disorder Market Share by Type (2014-2019)
Table China Major Depressive Disorder Market Size by Application (2014-2019) (Million US$)
Table China Major Depressive Disorder Market Share by Application (2014-2019)
Figure Japan Major Depressive Disorder Market Size 2014-2019 (Million US$)
Table Japan Key Players Major Depressive Disorder Revenue (2018-2019) (Million US$)
Table Japan Key Players Major Depressive Disorder Market Share (2018-2019)
Table Japan Major Depressive Disorder Market Size by Type (2014-2019) (Million US$)
Table Japan Major Depressive Disorder Market Share by Type (2014-2019)
Table Japan Major Depressive Disorder Market Size by Application (2014-2019) (Million US$)
Table Japan Major Depressive Disorder Market Share by Application (2014-2019)
Figure Southeast Asia Major Depressive Disorder Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Major Depressive Disorder Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Major Depressive Disorder Market Share (2018-2019)
Table Southeast Asia Major Depressive Disorder Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Major Depressive Disorder Market Share by Type (2014-2019)
Table Southeast Asia Major Depressive Disorder Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Major Depressive Disorder Market Share by Application (2014-2019)
Figure India Major Depressive Disorder Market Size 2014-2019 (Million US$)
Table India Key Players Major Depressive Disorder Revenue (2018-2019) (Million US$)
Table India Key Players Major Depressive Disorder Market Share (2018-2019)
Table India Major Depressive Disorder Market Size by Type (2014-2019) (Million US$)
Table India Major Depressive Disorder Market Share by Type (2014-2019)
Table India Major Depressive Disorder Market Size by Application (2014-2019) (Million US$)
Table India Major Depressive Disorder Market Share by Application (2014-2019)
Figure Central & South America Major Depressive Disorder Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Major Depressive Disorder Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Major Depressive Disorder Market Share (2018-2019)
Table Central & South America Major Depressive Disorder Market Size by Type (2014-2019) (Million US$)
Table Central & South America Major Depressive Disorder Market Share by Type (2014-2019)
Table Central & South America Major Depressive Disorder Market Size by Application (2014-2019) (Million US$)
Table Central & South America Major Depressive Disorder Market Share by Application (2014-2019)
Table Pfizer Company Details
Table Pfizer Revenue in Major Depressive Disorder Business (2014-2019) (Million US$)
Figure Pfizer Revenue Growth Rate in Major Depressive Disorder Business (2014-2019)
Table Pfizer Recent Development
Table Eli Lilly Company Details
Table Eli Lilly Revenue in Major Depressive Disorder Business (2014-2019)(Million US$)
Figure Eli Lilly Revenue Growth Rate in Major Depressive Disorder Business (2014-2019)
Table Eli Lilly Recent Development
Table H. Lundbeck Company Details
Table H. Lundbeck Revenue in Major Depressive Disorder Business (2014-2019)(Million US$)
Figure H. Lundbeck Revenue Growth Rate in Major Depressive Disorder Business (2014-2019)
Table H. Lundbeck Recent Development
Table Otsuka Pharmaceutical Company Details
Table Otsuka Pharmaceutical Revenue in Major Depressive Disorder Business (2014-2019)(Million US$)
Figure Otsuka Pharmaceutical Revenue Growth Rate in Major Depressive Disorder Business (2014-2019)
Table Otsuka Pharmaceutical Recent Development
Table AstraZeneca Company Details
Table AstraZeneca Revenue in Major Depressive Disorder Business (2014-2019)(Million US$)
Figure AstraZeneca Revenue Growth Rate in Major Depressive Disorder Business (2014-2019)
Table AstraZeneca Recent Development
Table Alkermes Company Details
Table Alkermes Revenue in Major Depressive Disorder Business (2014-2019)(Million US$)
Figure Alkermes Revenue Growth Rate in Major Depressive Disorder Business (2014-2019)
Table Alkermes Recent Development
Table Takeda Pharmaceutical Company Details
Table Takeda Pharmaceutical Revenue in Major Depressive Disorder Business (2014-2019)(Million US$)
Figure Takeda Pharmaceutical Revenue Growth Rate in Major Depressive Disorder Business (2014-2019)
Table Takeda Pharmaceutical Recent Development
Table Naurex Company Details
Table Naurex Revenue in Major Depressive Disorder Business (2014-2019)(Million US$)
Figure Naurex Revenue Growth Rate in Major Depressive Disorder Business (2014-2019)
Table Naurex Recent Development
Table Euthymics Bioscience Company Details
Table Euthymics Bioscience Revenue in Major Depressive Disorder Business (2014-2019)(Million US$)
Figure Euthymics Bioscience Revenue Growth Rate in Major Depressive Disorder Business (2014-2019)
Table Euthymics Bioscience Recent Development
Table E-therapeutics Company Details
Table E-therapeutics Revenue in Major Depressive Disorder Business (2014-2019)(Million US$)
Figure E-therapeutics Revenue Growth Rate in Major Depressive Disorder Business (2014-2019)
Table E-therapeutics Recent Development
Table Global Major Depressive Disorder Market Size by Regions (Million US$) 2019-2025
Figure Global Major Depressive Disorder Market Size Share by Regions (2019-2025)
Figure Global Major Depressive Disorder Market Size Share by Regions in 2025
Figure United States Major Depressive Disorder Market Size Forecast (2019-2025)(Million USD)
Figure Europe Major Depressive Disorder Market Size Forecast (2019-2025)(Million USD)
Figure China Major Depressive Disorder Market Size Forecast (2019-2025)(Million USD)
Figure Japan Major Depressive Disorder Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Major Depressive Disorder Market Size Forecast (2019-2025)(Million USD)
Figure India Major Depressive Disorder Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Major Depressive Disorder Market Size Forecast (2019-2025)(Million USD)
Table Global Major Depressive Disorder Market Size by Product (2019-2025) (Million US$)
Figure Global Major Depressive Disorder Market Size by Product (2019-2025)
Figure Global Major Depressive Disorder Market Size by Product in 2025
Table Global Major Depressive Disorder Market Size by Application (2019-2025) (Million US$)
Figure Global Major Depressive Disorder Market Size by Application (2019-2025)
Figure Global Major Depressive Disorder Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
世界の大うつ病性障害市場：市場規模・現状・予測 Major depressive disorder, also known as major depression and clinical depression, is a mental disorder characterized by loss of interest and pleasure in enjoyable environment. People are affected in different ways by major depression. Some people have trouble sleeping, feel agitated and irritable, …- 世界のうつ病性障害市場：市場規模・現状・予測 Depression includes a variety of mental health problems characterized by the absence of a positive emotion, low mood, and a range of associated cognitive, physical, emotional, and behavioral symptoms. It is a very common condition that affects 1 in every 5 Americans. There are many factors including…
- 世界の季節性情動障害光療法市場：市場規模・現状・予測 Light therapy is a way to treat seasonal affective disorder (SAD) and certain other conditions by exposure to artificial light.In 2018, the global Seasonal Affective Disorder Light Therapy market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx…
- 世界のうつ病治療市場：市場規模・現状・予測 Depression is a mood disorder that causes a persistent feeling of sadness and loss of interest.One of the major factors for such low growth is a rapid decline in the revenue of branded drug manufacturers and growing strength of generic drug manufacturers. The introduction of virtual reality in the t…
- 世界の色素沈着障害市場：市場規模・現状・予測 Skin pigmentation refers to a skin disorder that causes either lightening of skin or darkening of skin when compared to the existing skin color.Pigmentation therapies can be classified as topical drugs, microdermabrasion, chemical peels, phototherapy, and laser therapy. These therapies are available…